Physician profile
Jad Mroue
NPI 1275988792
$13,374.58
in general payments reported to CMS, 2019-2025
9 companies · $949 in 2025
The $949 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $415 · 2023: $9,515 · 2024: $2,495 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,091 · Travel and Lodging: $2,211 · Food and Beverage: $1,567 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,091.00 |
| Travel and Lodging | $2,211.34 |
| Food and Beverage | $1,566.92 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,717.95 | 2023-2025 | Mitraclip, Triclip |
| Edwards Lifesciences Corporation | $1,637.42 | 2023-2025 | Evoque, Sapien 3 Ultra Resilia |
| Abiomed | $555.37 | 2022-2024 | Impella |
| Astrazeneca Pharmaceuticals Lp | $165.00 | 2022-2023 | Brilinta |
| Boston Scientific Corporation | $136.23 | 2023-2024 | Avvigo Guidance System, Watchman Access System |
| Medtronic, INC. | $82.29 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.87 | 2023-2024 | Jardiance |
| Asahi Intecc USA, INC. | $28.93 | 2024 | Peripheral Vascular |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.52 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jad Mroue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.